Pfizer PGN 225 (Lyrica 225 mg)
Generic Name: pregabalin
Pill with imprint Pfizer PGN 225 is Orange & White, Capsule-shape and has been identified as Lyrica 225 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Lyrica is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 225 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for Pfizer PGN 225
Lyrica
- Generic Name:
- pregabalin
- Imprint:
- Pfizer PGN 225
- Strength:
- 225 mg
- Color:
- Orange & White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00071-1019
- Inactive Ingredients:
-
- lactose monohydrate
- corn starch
- magnesium silicate
- titanium dioxide
- sodium lauryl sulfate
- silicon dioxide
- ferric oxide red
- shellac
- ferrosoferric oxide
- propylene glycol
- potassium hydroxide
Note: Inactive ingredients may vary.
More about Lyrica (pregabalin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 696 Reviews
- Generic Availability
- Drug class: gamma-aminobutyric acid analogs
- FDA Alerts (2)
- FDA Approval History
Consumer resources
Other brands: Lyrica CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
